Skip to main content

Day: July 24, 2020

Novartis Adakveo® receives positive CHMP opinion for the prevention of recurrent vaso-occlusive crises in patients with sickle cell disease

If approved, Adakveo would be the first targeted sickle cell disease therapy available for use in EuropeCHMP opinion supported by data showing Adakveo significantly reduced the rate of vaso-occlusive crises, with patients on Adakveo spending fewer days in hospitalVaso-occlusive crises are sudden, unpredictable, and associated with an increased risk of organ damage and mortality1Basel, July 24, 2020 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending conditional marketing authorization of Adakveo® (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or pain crises, in patients with sickle cell disease aged 16 years and older. Adakveo can be given as an add-on therapy to hydroxyurea/hydroxycarbamide...

Continue reading

Strong wireless customer additions and cash flow highlight Verizon’s 2Q and first-half 2020 results

Disciplined network strategy, strong operational performance, and wireless customer growth2Q 2020 highlightsConsolidated:$1.13 in earnings per share (EPS), compared with $0.95 in 2Q 2019; adjusted EPS (non-GAAP), excluding special items, of $1.18, compared with $1.23 in 2Q 2019.Operating revenue decline of 5.1 percent from second-quarter 2019.First-half 2020 cash flow from operations of $23.6 billion, an increase of $7.7 billion from first-half 2019.Second-quarter 2020 total debt reduction of $4.9 billion, and net debt (non-GAAP) reduction of $5.7 billion.Consumer:Total revenue of $21.1 billion, a decrease of 4.0 percent year over year.72,000 retail postpaid net additions, including 97,000 phone net additions and 199,000 postpaid smartphone net additions.Total retail postpaid churn of 0.69 percent, and retail postpaid phone churn of 0.51...

Continue reading

Freshii Inc. Announces Conference Call to Discuss Second Quarter 2020 Results

TORONTO, July 24, 2020 (GLOBE NEWSWIRE) — Freshii Inc. (TSX: FRII), the growing health and wellness brand, will host a conference call to discuss its second quarter 2020 financial results on Friday, August 14, 2020 at 8:30 a.m. Eastern Time.Hosting the call will be Matthew Corrin, Chairman and Chief Executive Officer, Daniel Haroun, Chief Financial Officer, and Paul Hughes, General Counsel and Chief Business Development Officer.Alternatively, the conference call will be webcast on the investor relations section of Freshii’s corporate website at www.freshii.inc. For those unable to participate, an audio replay will be available from 11:30 a.m. Eastern Time on Friday August 14, 2020 through Friday August 21, 2020. To access the replay, please call 1-844-512-2921 (U.S. & Canada) or 1-412-317-6671 (International) and enter confirmation...

Continue reading

55 North Mining Inc. Announces Resignation of Director

TORONTO, July 24, 2020 (GLOBE NEWSWIRE) — 55 North Mining Inc. (“55 North” or the “Company”) announces that Brien Sirola has resigned as a director of the Company for personal reasons.  Bruce Reid, President and Chief Executive Officer, commented: “Brien has contributed immensely to 55 North’s development over the years, and his contribution will be sorely missed.  We wish him all the best in his future endeavours.”About 55 North Inc.55 North Mining Inc. was incorporated under the Canada Business Corporations Act on December 5, 2008. The current business of the Company is exploration and development of its mineral properties. On June 29, 2020, 55 North announced that it had entered into a binding letter of intent to acquire the high grade Last Hope Gold Project located in Manitoba, Canada. On July 3, 2020, 55 North announced that...

Continue reading

Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)

TORONTO, July 24, 2020 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce call-in numbers and webcast link for the Annual General and Special Meeting of the shareholders of Blueberries Medical Corp. (the “AGM”).  The AGM will be held on Friday, July 31, 2020 at 1:00 pm Eastern Time at 82 Richmond Street East, Toronto, Ontario, Canada M5C 1P1.In response to the ongoing global COVID-19 pandemic, the board of directors of Blueberries is advising shareholders not to attend the AGM in-person. After considering recent Provincial and Federal guidance regarding public gatherings and to proactively protect the health and well-being of Blueberries’ shareholders,...

Continue reading

Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®

SPRAVATO® (esketamine) nasal spray uses the first new mechanism of action in decades to treat treatment resistant depression disorder Aleafia Health medical clinics along with select physicians and nurses now approved to administer and prescribe, following completion of Janssen Journey certificationOffering expands Aleafia’s health and wellness solutions to existing and prospective patients across CanadaSPRAVATO® approved by the U.S. Food and Drug Administration and Health CanadaTORONTO, July 24, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced that Janssen Pharmaceuticals, Inc. (“Janssen”), has approved its wholly owned subsidiary, Canabo Medical Inc. (“Canabo”) as an administrator and prescriber of antidepressant SPRAVATO® (esketamine) nasal spray. Three...

Continue reading

Medigus: ScoutCam Announced Acceptance of $2.4M Quote from a Fortune 500 Multinational Healthcare Corporation

Following Acceptance of $2.4M Quote, Preeminent Visual Solutions Creator will Develop Customized Products for Medical Supplies GiantOMER, Israel, July 24, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that it was informed by ScoutCam Inc. (OTC: SCTC), the Medigus’ subsidiary and a leading developer and manufacturer of customized visual solutions and supplementary technologies, that ScoutCam Ltd., ScoutCam’s wholly-owned subsidiary and Medigus’ indirect subsidiary, accepted a quote of $2.4 million for its single-use miniature video cameras from a Fortune 500 multinational healthcare corporation. According to the terms of this commitment, the two companies will work together to develop a complete...

Continue reading

Orange Belgium once more shakes the market with an unseen price on the football option and a major data boost for all GO Plus subscribers

Press ReleaseBrussels, 24th July 2020Orange Belgium once more shakes the market with an unseen price on the football option and a major data boost for all GO Plus subscribersAs previously announced, Orange Belgium and Eleven Sports have reached a deal regarding the rights for the Jupiler Pro League, allowing every Orange Belgium customers – convergent or mobile only – to watch Belgian football. Orange Belgium goes further in making football content accessible, with an ultra competitive pricing of only 10.99 euros for the new package, including 3 new dedicated sport channels. And to make sure Orange’s customers never miss the content they love, the data cap of the GO Plus subscription has been upped from 5 to 8GB, automatically and for free for every customers (new and actuals).10.99 euros for Orange’s Belgian Football packOrange...

Continue reading

Orange Belgium zorgt opnieuw voor opschudding op de markt met een ongeziene prijs voor zijn voetbaloptie en een grote databoost voor alle GO Plus-abonnees

PersberichtBrussel, 24 juli 2020Orange Belgium zorgt opnieuw voor opschudding op de markt met een ongeziene prijs voor zijn voetbaloptie en een grote databoost voor alle GO Plus-abonneesZoals eerder aangekondigd, bereikten Orange Belgium en Eleven Sports een deal omtrent de voetbalrechten van de Jupiler Pro League. Hierdoor kunnen alle Orange Belgium-klanten met een convergente of enkel een mobiele oplossing Belgisch voetbal kijken. Orange Belgium maakt voetbal nu nog toegankelijker met een uitermate competitieve prijs van amper 10,99 euro voor dit nieuwe Football pack met 3 nieuwe speciale sportkanalen. En om zeker te zijn dat de klanten nooit iets van hun favoriete content hoeven te missen, trekt Orange voor alle bestaande en nieuwe klanten de datalimiet van zijn GO Plus-abonnement automatisch en zonder meerkost op van 5 GB naar 8 GB.10,99...

Continue reading

Orange Belgium secoue une fois encore le marché avec un prix inédit sur l’option football et une augmentation considérable des données pour tous les détenteurs d’un abonnement GO Plus

Communiqué de presseBruxelles, le 24 juillet 2020Orange Belgium secoue une fois encore le marché avec un prix inédit sur l’option football et une augmentation considérable des données pour tous les détenteurs d’un abonnement GO PlusComme annoncé précédemment, Orange Belgium et Eleven Sports ont conclu un accord sur les droits de la Jupiler Pro League, permettant à tous les clients d’Orange Belgium (convergents ou mobiles uniquement) de regarder le football belge. Orange Belgium va plus loin en donnant accès à du contenu footballistique au prix ultracompétitif de seulement 10,99 euros pour le nouveau pack, qui inclut 3 nouvelles chaînes sportives dédiées. Et pour s’assurer que ses clients ne manquent jamais le contenu qu’ils aiment, Orange a porté la limite de données de l’abonnement GO Plus de 5 à 8 GB, automatiquement et gratuitement...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.